BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 26807478)

  • 1. Prevention of vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia by CREB-mediated p21 induction: An insight from a plant polyphenol.
    Sun L; Zhao R; Zhang L; Zhang W; He G; Yang S; Song J; Du G
    Biochem Pharmacol; 2016 Mar; 103():40-52. PubMed ID: 26807478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilostazol promotes vascular smooth muscles cell differentiation through the cAMP response element-binding protein-dependent pathway.
    Chen WJ; Chen YH; Lin KH; Ting CH; Yeh YH
    Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2106-13. PubMed ID: 21680899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salt-Inducible Kinase 3 Promotes Vascular Smooth Muscle Cell Proliferation and Arterial Restenosis by Regulating AKT and PKA-CREB Signaling.
    Cai Y; Wang XL; Lu J; Lin X; Dong J; Guzman RJ
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2431-2451. PubMed ID: 34196217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wedelolactone, a plant coumarin, prevents vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia through Akt and AMPK signaling.
    Peng L; Huang X; Jin X; Jing Z; Yang L; Zhou Y; Ren J; Zhao Y
    Exp Gerontol; 2017 Oct; 96():73-81. PubMed ID: 28634089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.
    Cai Y; Nagel DJ; Zhou Q; Cygnar KD; Zhao H; Li F; Pi X; Knight PA; Yan C
    Circ Res; 2015 Mar; 116(7):1120-32. PubMed ID: 25608528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migration.
    Jalvy S; Renault MA; Leen LL; Belloc I; Bonnet J; Gadeau AP; Desgranges C
    Cardiovasc Res; 2007 Sep; 75(4):738-47. PubMed ID: 17574222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K.
    Torella D; Gasparri C; Ellison GM; Curcio A; Leone A; Vicinanza C; Galuppo V; Mendicino I; Sacco W; Aquila I; Surace FC; Luposella M; Stillo G; Agosti V; Cosentino C; Avvedimento EV; Indolfi C
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2015-25. PubMed ID: 19783773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDGF-BB-mediated activation of CREB in vascular smooth muscle cells alters cell cycling via Rb, FoxO1 and p27
    Perrault R; Molnar P; Poole J; Zahradka P
    Exp Cell Res; 2021 Jul; 404(1):112612. PubMed ID: 33895117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells.
    Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ
    Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfur dioxide inhibits vascular smooth muscle cell proliferation via suppressing the Erk/MAP kinase pathway mediated by cAMP/PKA signaling.
    Liu D; Huang Y; Bu D; Liu AD; Holmberg L; Jia Y; Tang C; Du J; Jin H
    Cell Death Dis; 2014 May; 5(5):e1251. PubMed ID: 24853429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of PI3K regulatory subunit p55γ as a novel inhibitor of vascular smooth muscle cell proliferation and neointimal formation.
    Li G; Xie N; Yao Y; Zhang Y; Guo J; Feng Y; Lv F; Xiao RP; Cao CM
    Cardiovasc Res; 2015 Jan; 105(1):75-85. PubMed ID: 25388664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
    Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
    Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
    Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
    J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
    Kim SY; Jeoung NH; Oh CJ; Choi YK; Lee HJ; Kim HJ; Kim JY; Hwang JH; Tadi S; Yim YH; Lee KU; Park KG; Huh S; Min KN; Jeong KH; Park MG; Kwak TH; Kweon GR; Inukai K; Shong M; Lee IK
    Circ Res; 2009 Apr; 104(7):842-50. PubMed ID: 19229058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phloretin Inhibits Platelet-derived Growth Factor-BB-induced Rat Aortic Smooth Muscle Cell Proliferation, Migration, and Neointimal Formation After Carotid Injury.
    Wang D; Wang Q; Yan G; Qiao Y; Tang C
    J Cardiovasc Pharmacol; 2015 May; 65(5):444-55. PubMed ID: 25945863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP.
    McKean JS; Murray F; Gibson G; Shewan DA; Tucker SJ; Nixon GF
    Cardiovasc Res; 2015 Sep; 107(4):546-55. PubMed ID: 26092100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation.
    Wu YJ; Bond M; Sala-Newby GB; Newby AC
    Circ Res; 2006 May; 98(9):1141-50. PubMed ID: 16574903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.